XXIX Metal Corp. (QCCUF)

ShockWave Medical Income Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Selling, General & Admin	1.24	1.03	0.69	0.84	0.76	0.44
Operating Expenses	15.63	2.75	4.82	10.04	7.08	1.42
Operating Income	-15.63	-2.75	-4.82	-10.04	-7.08	-1.42
Interest & Investment Income	0.17	0.23	0.3	0.15	-	-
Earnings From Equity Investments	-	-	-	-0.19	-1.76	-0.03
Other Non Operating Income (Expenses)	-0.32	-0.17	-0.16	-0.32	-0.41	-0.13
EBT Excluding Unusual Items	-15.78	-2.68	-4.68	-10.4	-9.25	-1.58
Gain (Loss) on Sale of Investments	-2.03	-2.18	-2.65	3.88	9.07	0.08
Gain (Loss) on Sale of Assets	-	-	-	-	-	3.87
Pretax Income	-17.81	-4.86	-7.32	-6.52	-0.18	2.37
Income Tax Expense	-	-	-	-2.61	-0.66	0.04
Net Income	-17.81	-4.86	-7.32	-3.91	0.48	2.32
Net Income to Common	-17.81	-4.86	-7.32	-3.91	0.48	2.32
Net Income Growth	-	-	-	-	-79.26%	-
Shares Outstanding (Basic)	207	174	162	146	110	56
Shares Outstanding (Diluted)	207	174	162	146	124	57
Shares Change (YoY)	20.00%	7.35%	10.76%	17.60%	116.90%	61.30%
EPS (Basic)	-0.09	-0.03	-0.05	-0.03	0.00	0.04
EPS (Diluted)	-0.09	-0.03	-0.05	-0.03	0.00	0.04
EPS Growth	-	-	-	-	-90.31%	-
Free Cash Flow	-2.99	-1.69	-4.42	-10.07	-5.93	-1.09
Free Cash Flow Per Share	-0.01	-0.01	-0.03	-0.07	-0.05	-0.02
EBITDA	-15.61	-2.73	-4.81	-10.03	-7.07	-1.42
D&A For EBITDA	0.02	0.01	0.01	0.02	0.01	0
EBIT	-15.63	-2.75	-4.82	-10.04	-7.08	-1.42
Effective Tax Rate	-	-	-	-	-	1.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.